MARK2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-71889
Conjugate
Catalog #
Key Product Details
Validated by
Independent Antibodies
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1.0 mg/ml
Product Specifications
Immunogen
The immunogen for this product maps to a region between residue 300 and 350 of human MAP/microtubule Affinity-Regulating Kinase 2 using the numbering given in entry NP_001034558.2 (GeneID 2011).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for MARK2 Antibody
Western Blot: MARK2 Antibody [NBP1-71889]
Western Blot: MARK2 Antibody [NBP1-71889] - Whole cell lysate (1 mg for IP, 20% of IP loaded) from 293T cells. Affinity purified rabbit anti-MARK2 antibody used for IP at 6 mcg/mg lysate. MARK2 was also immunoprecipitated by rabbit anti-MARK2 antibody NBP1-71890, which recognizes a downstream epitope.Applications for MARK2 Antibody
Application
Recommended Usage
Immunoprecipitation
2-10 mcg/mg
Western Blot
1:2000-1:10000
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: MARK2
Alternate Names
EC 2.7.11, EC 2.7.11.1, ELKL motif kinase, ELKL motif kinase 1, EMK-1, EMK1PAR-1, MAP/microtubule affinity-regulating kinase 2MGC99619, PAR1 homolog, Par1b, Ser/Thr protein kinase PAR-1B, serine/threonine protein kinase EMK, serine/threonine-protein kinase MARK2
Gene Symbol
MARK2
UniProt
Additional MARK2 Products
Product Documents for MARK2 Antibody
Product Specific Notices for MARK2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...